Skrining dan Diagnosis Melanoma Kulit
DOI:
https://doi.org/10.55175/cdk.v47i4.372Keywords:
Diagnosis, melanoma, skriningAbstract
Melanoma merupakan salah satu keganasan kulit yang paling berbahaya dan banyak menyebabkan kematian. Tanpa skrining dan diagnosis dini, tindakan preventif akan sangat sulit, sehingga akan meningkatkan morbiditas dan mortalitas.
Melanoma is one of the most dangerous skin malignancies and causes many death. Without early screening and diagnosis, preventive measures will be very difficult and may increase morbidity and mortality.
Downloads
References
Eggermont AM, Spatz A, Robert C. Cutaneous melanoma. Lancet 2014;383(9919):816-27.
Garbe C, Peris K, Hauschild A, Saiag P, Middleton M, Spatz A, et al. Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline. Eur J Cancer 2010;46(2):270-83.
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer 2013;49(6):1374-403.
Leiter U, Garbe C. Epidemiology of melanoma and non- melanoma skin cancerdthe role of sunlight. Adv Exp Med Biol. 2008;624:89-103.
Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol. 2009;27(1):3-9.
Whiteman DC, Green AC, Olsen CM. The growing burden of invasive melanoma: Projections of incidence rates and numbers of new cases in six susceptible populations to 2031. J Invest Dermatol. 2016;136(6):1161-71.
Bauer J, Garbe C. Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological data. Pigment Cell Res. 2003;16(3):297-306.
McGovern VJ, Mihm Jr MC, Bailly C, Booth JC, Clark Jr WH, Cochran AJ, et al. The classification of malignant melanoma and its histologic reporting. Cancer 1973;32(6):1446-57.
Nettina SM. Lippincott Manual of Nursing Practice. 10th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2014 .p. 1166.
Goodheart HP. Goodheart’s photo guide to common skin disorders diagnosis and management. 3rd ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2009 .p. 421.
Olsen CM, Knight LL, Green AC. Risk of melanoma in people with HIV/ AIDS in the pre- and post-HAART eras: A systematic review and meta-analysis of cohort studies. PloS One. 2014;9(4):95096.
Anderson WF, Pfeiffer RM, Tucker MA, Rosenberg PS. Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma. Cancer. 2009;115(18):4176-85.
Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009;27(36):6199-206.
American Cancer Society. Cancer facts & figures 2015. doi:10.3322/caac.21254
American Cancer Society. Melanoma skin cancer what is cancer? [Internet]. 2019 Aug 14 [cited 2020 March 22]. Available from: https://www.cancer.org/cancer/melanoma-skin-cancer/about/what-is-melanoma.html
Wurm EM, Soyer HP. Scanning for melanoma. Aust Prescr. 2010;33:150-5.
Mayer J. Systematic review of the diagnostic accuracy of dermatoscopy in detecting malignant melanoma. Med J Aust. 1997;167:206–10.
Menzies SW, Bischof L, Talbot H, Gutenev A, Avramidis M, Weng L, et al. The performance of SolarScan: An automated dermoscopy image analysis instrument for the diagnosis of primary melanoma. Arch Dermatol. 2005;141:1388–96.
Tsao H, Olazagasti JM, Cordoro KM, Brewer JD, Taylor S, Bordeaux JS, et al. Early detection of melanoma: Reviewing the ABCDEs. Journal of the American Academy of Dermatology 2015;72(4):717-23 .
Russak JE, Friedman RJ. The evolution of melanoma diagnosis: 25 years beyond the ABCDs. CA: a cancer journal for clinicians 2010;60(5):301-16 .
Kittler H, Pehamberger H, Wolff K, Binder M. Diagnostic accuracy of dermoscopy. Lancet Oncol. 2002;3(3):159-65.
Menzies SW, Ingvar C, McCarthy WH. A sensitivity and specificity analysis of the surface microscopy features of invasive melanoma. Melanoma Res. 1996;6(1):55-62.
Argenziano G, Soyer HP, Chimenti S, Talamini R, Corona R, Sera F, et al. Dermoscopy of pigmented skin lesions: Results of a consensus meeting via the Internet. J Am Acad Dermatol. 2003;48(5):679-93.
Kittler H, Guitera P, Riedl E, Avramidis M, Teban L, Fiebiger M, et al. Identification of clinically featureless incipient melanoma using sequential dermoscopy imaging. Arch Dermatol. 2006;142(9):1113-9.
Pizzichetta MA, Stanganelli I, Bono R, Soyer HP, Magi S, Canzonieri V, et al. Dermoscopic features of difficult melanoma. Dermatol Surgery 2007;33(1):91-9.
Stolz W, Schiffner R, Burgdorf WH. Dermatoscopy for facial pigmented skin lesions. Clin Dermatol. 2002;20(3):276-8.
Schiffner R, Schiffner-Rohe J, Vogt T, Landthaler M, Wlotzke U, Cognetta AB, et al. Improvement of early recognition of lentigo maligna using dermatoscopy. J Am Acad Dermatol. 2000;42(1 Pt 1):25-32.
Pralong P, Bathelier E, Dalle S, Poulalhon N, Debarbieux S, Thomas L. Dermoscopy of lentigo maligna melanoma: Report of 125 cases. Br J Dermatol. 2012;167(2):280-7.
Koga H, Saida T. Revised 3-step dermoscopic algorithm for the management of acral melanocytic lesions. Arch Dermatol. 2011;147(6):741-3.
Kittler H, Binder M. Follow-up of melanocytic skin lesions with digital dermoscopy: risks and benefits. Arch Dermatol 2002; 138(10):1379.
Haenssle HA, Krueger U, Vente C, Thoms KM, Bertsch HP, Zutt M, et al. Results from an observational trial: digital epi- luminescence microscopy follow-up of atypical nevi increases the sensitivity and the chance of success of conventional dermoscopy in detecting melanoma. J Invest Dermatol 2006;126(5):980-5.
Gachon J, Beaulieu P, Sei JF, Gouvernet J, Claudel JP, Lemaitre M, et al. First prospective study of the recognition process of melanoma in dermatological practice. Arch Dermatol 2005;141(4):434-8.
Ruiter DJ, Spatz A, van den Oord JJ, Cook MG. Pathologic staging of melanoma. Semin Oncol 2002;29(4):370-81
Kohlhapp FJ, Zloza A, Kaufman HL. Talimogenelaherparepvec (T-VEC) as cancer immunotherapy. Drugs Today (Barc). 2015;51(9):549-58.
Gray-Schopfer V, Wellbrock C, Marais R. Melanoma biology and new targeted therapy. Nature. 2007;445(7130):851-7.
Boni A, et al. Selective BRAFV600E inhibition enhances T-cell recogni- tion of melanoma without affecting lymphocyte function. Cancer Res. 2010;70(13):5213-9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Cermin Dunia Kedokteran
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
